Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Sep 1, 2026
Safe Pro Group Inc. (SPAI)
A forensic read on Safe Pro Group Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Grey Zone
Financial health
8.3
Distress distance
Clean
Earnings quality
6
Forensic signals
-80.8%
ROE
-72.0%
Revenue growth
The financial-health reading above compares this company's equity at BOOK value, not at what the market currently pays for it — this free snapshot doesn't pull live market data. Treat it as a rough read, not the final word.
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Safe Pro Group Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 8.3, placing it in the Grey zone (based on book value, not market value, since this free snapshot doesn't pull live market data — treat this zone as a rough read, not the final word). 6 forensic signals were flagged in its latest SEC filings, led by accruals ratio (% of noa).
What the filings flag
+126.5%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +126.5% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building sharply — a large slice of profit sits in operating assets, not cash. An accrual is a claim that still has to be collected or written down, so the gap resolves in a later period whichever way it goes. The build is led by inventory up +80% against -68% in cost of sales. A cash-flow measure on the same base disagrees: reported earnings ran behind operating cash by 74% of net operating assets, against an accruals ratio of 126.5%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average. Read them as two results, not one.
60d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 21 to 60 days FY2024→FY2025 (receivables -19% vs revenue -72%). Receivables are outrunning sales — a flag for aggressive revenue recognition or slipping collections. There's no FY2023 figure on file for receivables, so FY2024 has no opening balance to average against — both figures are measured on period-end balances rather than the beginning-plus-ending average, since averaging only the current year would make the move track balance-sheet growth rather than the business.
555d
FY2024→FY2025
Inventory days.Days inventory outstanding moved from 99 to 555 FY2024→FY2025 (against cost of goods sold; inventory +80% vs -68% in cost of sales). Inventory is outrunning what's being sold — a flag for softening demand or obsolescence risk ahead. There's no FY2023 figure on file for inventory, so FY2024 has no opening balance to average against — both figures are measured on period-end balances rather than the beginning-plus-ending average, since averaging only the current year would make the move track balance-sheet growth rather than the business.
Key fundamentals
Latest Revenue$606,681.00
Revenue Growth YoY-72.0%
Net Margin-2360.8%
Free Cash Flow-$6.3M
Return on Equity-80.8%
Debt / Equity0.01x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Safe Pro Group Inc.'s actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Sep 1, 2026. Forensic signals flag probability, not certainty.
Safe Pro Group Inc. (SPAI) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
+59.3%/yr
FY2024–FY2025
Share-count dilution.Diluted share count changed +59% over the last 1 year to FY2025 (+59.3%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~59.3% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2024 has been diluted ~37%.
1.4% of rev
FY2025
Stock-based comp load.Stock-based compensation ran 1.4% of revenue in FY2025 — about $0.00 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 59.3% a year, above the level at which the count is a material claim on a stake, and only one year's change is on file — enough to state what a holder gave up, not enough to say whether the rate is climbing or coming down. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.
$684,867
FY2025–FY2025
Goodwill impairments.Took $684,867 of goodwill writedowns across 1 year (FY2025 ($684,867)). Writedowns mean past acquisitions underperformed what was paid for them.